Blog
RSS FeedPosted by Michael Wonder on 27 May 2020
FDA approves only drug in U.S. to treat severe malaria
26 May 2020 - Today, the U.S. FDA approved artesunate for injection to treat severe malaria in adult and paediatric patients. ...
Posted by Michael Wonder on 20 May 2020
A new entry in the race for a coronavirus vaccine: hope
20 May 2020 - Scientists are increasingly optimistic that a vaccine can be produced in record time. But getting it manufactured ...
Posted by Michael Wonder on 07 May 2020
The equitable distribution of COVID-19 therapeutics and vaccines
7 May 2020 - Scientists from across the globe are racing to develop effective vaccines and therapeutics for COVID-19. ...
Posted by Michael Wonder on 05 May 2020
Teva and Celltrion Healthcare announce the launch of Truxima (rituximab-abbs) injection for rheumatoid arthritis, the only biosimilar to Rituxan (rituximab) available in the United States for this indication
4 May 2020 - Truxima is also now available for the treatment of granulomatosis with polyangiitis (Wegener’s granulomatosis) and microscopic polyangiitis. ...
Posted by Michael Wonder on 30 Apr 2020
Google searches for unproven COVID-19 cures spike by 1000 per cent after Trump, Musk endorsements
30 April 2020 - They’re unproven cures for COVID-19, but that hasn’t stopped a massive spike in attempts to buy these ...
Posted by Michael Wonder on 29 Apr 2020
FDA in ‘ongoing’ talks with Gilead to make remdesivir available to coronavirus patients ‘as quickly as possible’
29 April 2020 - The FDA has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug ...
Posted by Michael Wonder on 27 Apr 2020
Vaccine could potentially be available later this year, coalition says
27 April 2020 - Group head hopes to deliver shots sooner than 12-18 months. ...
Posted by Michael Wonder on 16 Apr 2020
Japan, China vie to be global supplier of unproven coronavirus drug
16 April 2020 - Diplomatic tug of war over favipiravir comes despite lack of evidence that the drug works. ...
Posted by Michael Wonder on 15 Apr 2020
Science says Trump was right: malaria drugs need to be pursued as a coronavirus therapy
14 April 2020 - When President Donald Trump suggested that an off-labeled repurposing of a pair of old antimalarial drugs ...
Posted by Michael Wonder on 10 Apr 2020
Ensuring access to medications in the US during the COVID-19 pandemic
9 April 2020 - The coronavirus disease 2019 (COVID-19) pandemic continues to rapidly evolve. ...
Posted by Michael Wonder on 07 Apr 2020
Bristol Myers Squibb expands patient support programs to help newly uninsured patients in the U.S.
7 April 2020 - Bristol Myers Squibb today announced an expansion of its existing patient support programs to help eligible ...
Posted by Michael Wonder on 07 Apr 2020
New $35 co-pay now available through Lilly insulin value program in response to COVID-19 crisis in U.S.
7 April 2020 - Insulin savings available for people with commercial insurance and the uninsured by calling (833) 808-1234. ...
Posted by Michael Wonder on 07 Apr 2020
Trump’s aggressive advocacy of malaria drug for treating coronavirus divides medical community
6 April 2020 - While Dr. Anthony Fauci has urged caution in using hydroxychloroquine, some doctors are prescribing it to patients ...
Posted by Michael Wonder on 06 Apr 2020
An update on COVID-19 from Gilead Chairman & CEO
4 April 2020 - Over the course of the past week, Gilead has been working in consultation with regulatory authorities ...
Posted by Michael Wonder on 06 Apr 2020
Trump pushed health officials to make anti-malaria drugs available as coronavirus treatment: report
4 April 2020 - President Trump pushed health health officials to make anti-malaria drugs available to treat the coronavirus although ...